Vaginal Pessary Market Size, Share, Growth, and Industry Analysis, By Types (Ring Pessary, Shelf Pessary, Others), By Applications Covered (Mild Pelvic Organ Prolapse, Stress Urinary Incontinence, Severe Pelvic Organ Prolapse), Regional Insights and Forecast to 2033

Vaginal Pessary Market Size

The global vaginal pessary market was valued at USD 250.47 million in 2024 and is anticipated to reach USD 262.2 million in 2025, with further expansion to USD 377.8 million by 2033, reflecting a compound annual growth rate (CAGR) of 4.67% from 2025 to 2033.

The U.S. vaginal pessary market holds the largest share in North America, driven by high awareness, advanced healthcare facilities, and increasing cases of pelvic organ prolapse (POP). Around 50% of postmenopausal women experience POP, leading to growing pessary adoption.

The vaginal pessary market is experiencing significant growth due to the increasing prevalence of pelvic organ prolapse (POP) and urinary incontinence among women globally. Rising awareness about non-surgical treatment options, coupled with the growing geriatric population, is driving demand for vaginal pessaries. Manufacturers are focusing on biocompatible materials such as medical-grade silicone to enhance patient comfort and safety. The availability of customizable and self-care pessaries is further expanding the market reach. Moreover, the increasing adoption of telehealth services and direct-to-consumer sales is enhancing accessibility, making vaginal pessaries a preferred choice among both healthcare professionals and patients.

Vaginal Pessary Market Trends

The vaginal pessary market is evolving with key trends shaping its growth trajectory. One of the primary trends is the increasing adoption of silicone-based pessaries, which now account for approximately 65% of the total market share, owing to their durability and hypoallergenic properties. Additionally, self-care pessaries are gaining popularity, with a 30% rise in patient preference for home-use devices over the past five years.

The e-commerce segment in the vaginal pessary market has witnessed a 40% growth in sales, as more consumers prefer the convenience of online purchases. This shift is further fueled by a 50% increase in telemedicine consultations for pelvic health issues, allowing patients to receive remote medical guidance on pessary usage.

In terms of product types, ring pessaries hold the largest market share at 45%, followed by Gellhorn pessaries at 25% and cube pessaries at 15%. The demand for advanced and customized pessaries has surged by 35%, driven by increasing cases of pelvic organ prolapse, which affects nearly 50% of women over 50.

Geographically, North America dominates the market with a 40% share, while Europe follows at 30%. Meanwhile, the Asia-Pacific region is growing at a rapid pace, with a 25% increase in pessary adoption, largely due to rising healthcare awareness and improved access to gynecological care.

Vaginal Pessary Market Dynamics

The vaginal pessary market is influenced by multiple factors, including increasing cases of pelvic organ prolapse (POP) and urinary incontinence, technological advancements in biocompatible materials, and the expansion of online retail and telehealth services. While the market continues to expand due to rising demand, challenges such as low patient awareness, lack of skilled healthcare professionals, and product-associated complications hinder its full potential. However, growing acceptance of non-surgical treatment options and research into advanced pessary designs present significant opportunities.

Drivers of Market Growth

"Increasing Prevalence of Pelvic Organ Prolapse and Urinary Incontinence"

The growing prevalence of pelvic organ prolapse (POP), affecting nearly 50% of women over 50, is a significant driver for the vaginal pessary market. Around 30% of women experiencing stress urinary incontinence prefer non-surgical solutions like pessaries over invasive procedures. The increasing global aging population, with over 20% of women above 60 suffering from pelvic floor disorders, further drives demand. Additionally, the rise in post-partum complications has led to a 25% increase in pessary prescriptions among younger women.

Market Restraints

"Low Awareness and Limited Adoption in Developing Regions"

Despite the increasing prevalence of pelvic floor disorders, awareness about vaginal pessaries remains low in developing economies, where nearly 60% of affected women do not seek treatment due to stigma or lack of information. The limited presence of trained gynecologists, particularly in rural areas, restricts access to pessary fittings and follow-up care. Additionally, 20% of pessary users report complications such as vaginal irritation and discharge, leading to discontinuation. These factors collectively hinder market growth, especially in regions like Africa, Latin America, and parts of Asia.

Market Opportunities

"Expansion of Telehealth and E-commerce Distribution"

The rise of digital health platforms and e-commerce channels is transforming the vaginal pessary market. Online sales of medical devices have surged by 40%, with a 35% increase in direct-to-consumer pessary purchases. Telemedicine has witnessed a 50% rise in gynecological consultations, enabling remote diagnosis and treatment recommendations for pelvic organ prolapse. Furthermore, subscription-based home-delivery services for pessary replacements have grown by 20%, improving patient adherence and long-term use. These advancements are creating lucrative opportunities for manufacturers to expand their reach, especially in underserved regions.

Market Challenges

"High Rate of Pessary Discontinuation Due to Side Effects"

One of the major challenges in the vaginal pessary market is the high discontinuation rate, with nearly 30% of users stopping pessary use within the first year due to discomfort, vaginal infections, and improper fit. Studies indicate that 20% of pessary users experience recurring vaginal discharge and irritation, requiring frequent follow-ups and adjustments. Additionally, healthcare providers report that 15% of patients require a pessary removal due to complications such as erosion or ulceration. Lack of patient education on proper insertion, maintenance, and hygiene practices further exacerbates this challenge, limiting market penetration.

Segmentation Analysis

The vaginal pessary market is segmented based on type and application, with different pessary designs catering to varying severity levels of pelvic organ prolapse (POP) and urinary incontinence. Among the various types, ring pessaries are the most commonly used, while shelf pessaries and other specialized designs serve specific patient needs. The application segment is primarily driven by the increasing prevalence of mild to severe pelvic organ prolapse and stress urinary incontinence, each requiring tailored pessary solutions for effective symptom management.

By Type

• Ring Pessary: Ring pessaries hold approximately 45% of the market share, making them the most widely used type due to their flexibility, ease of insertion, and comfort. They are commonly recommended for mild to moderate pelvic organ prolapse (POP) and stress urinary incontinence (SUI). Among women opting for non-surgical treatments, nearly 60% choose ring pessaries due to their ability to provide immediate symptom relief. The increasing preference for self-inserted and removable pessaries has led to a 35% increase in demand for silicone-based ring pessaries, which reduce the risk of irritation and infections.

• Shelf Pessary: Shelf pessaries, accounting for approximately 25% of the vaginal pessary market, are preferred for moderate to severe cases of pelvic organ prolapse where additional support is needed. Unlike ring pessaries, shelf pessaries are rigid and provide better structural support for patients with significant vaginal wall descent. They are commonly used in patients where surgical intervention is not an option due to age, comorbidities, or personal preference. Studies show that nearly 40% of women using shelf pessaries require professional assistance for insertion and removal, making regular follow-up appointments necessary.

• Other Pessaries (Gellhorn, Cube, Donut, etc.): Other pessary types, such as Gellhorn, cube, and donut pessaries, collectively hold around 30% of the market share. These are specifically designed for severe cases of pelvic organ prolapse where standard ring or shelf pessaries are ineffective. Gellhorn pessaries are preferred for advanced-stage prolapse, especially in postmenopausal women, with a 25% adoption rate among patients with stage III or IV prolapse. Cube pessaries, known for their suction-like grip, are increasingly recommended for patients with prior surgical failure, with usage growing by 20% in recent years.

By Application

• Mild Pelvic Organ Prolapse: Mild pelvic organ prolapse (POP) affects nearly 30% of women over 40, with symptoms such as vaginal bulging and mild discomfort. Ring pessaries are the preferred option, accounting for 70% of pessary prescriptions in early-stage POP cases. Among patients diagnosed with mild prolapse, 50% choose pessaries over surgical options, with growing awareness about non-invasive treatment alternatives driving adoption. The increasing use of hormone therapy in combination with pessary treatment has further improved long-term outcomes for postmenopausal women.

• Stress Urinary Incontinence (SUI): Stress urinary incontinence (SUI) is a common condition among 20% of women aged 35 and above, often exacerbated by pregnancy, obesity, or menopause. Ring pessaries with support are the most widely used devices for SUI management, accounting for 55% of the pessary market for urinary incontinence cases. With an increase in non-surgical treatment preferences, 30% of gynecologists report prescribing pessaries as a first-line treatment before considering surgical intervention. Self-inserted pessaries have seen a 40% rise in adoption, particularly among younger women looking for temporary relief before exploring long-term solutions.

• Severe Pelvic Organ Prolapse: Severe pelvic organ prolapse (POP) is diagnosed in 15% of women over 60, with nearly 50% of cases requiring pessary support due to surgical risks or personal preference. Gellhorn and cube pessaries dominate this segment, with a 60% market share among severe POP cases. Studies indicate that 30% of patients with severe prolapse opt for pessaries as an alternative to surgery, while 20% use them as a pre-surgical intervention to improve symptoms before undergoing pelvic reconstructive procedures. The demand for high-support pessaries has increased by 25%, reflecting a shift towards long-term, non-surgical management strategies for severe cases.

Regional Outlook

The vaginal pessary market is expanding across multiple regions, with North America and Europe leading due to well-established healthcare systems and rising awareness about pelvic organ prolapse (POP) and urinary incontinence treatments. Meanwhile, the Asia-Pacific region is witnessing rapid growth, driven by improving gynecological care and increasing disposable incomes. Middle East & Africa, though a smaller market, is also seeing a gradual increase in demand due to rising healthcare infrastructure investments and awareness campaigns.

North America

North America dominates the vaginal pessary market, holding 40% of the global share, due to high awareness levels, advanced healthcare facilities, and a significant aging population. In the United States, over 50% of postmenopausal women experience some degree of pelvic organ prolapse, leading to a 35% increase in pessary prescriptions over the last decade. The region also sees a 45% adoption rate for self-managed pessaries, as more women prefer non-invasive treatments. Additionally, online sales of pessaries have grown by 30%, fueled by telemedicine services and e-commerce expansion.

Europe

Europe holds around 30% of the vaginal pessary market share, with Germany, the UK, and France leading in terms of product adoption. Nearly 45% of gynecologists in Europe recommend pessaries as the first line of treatment for mild to moderate pelvic organ prolapse. The demand for biocompatible silicone pessaries has grown by 40%, driven by patient preference for safer, long-term solutions. Additionally, government-backed women’s health programs in countries like Sweden and the Netherlands have contributed to a 20% rise in pessary awareness campaigns.

Asia-Pacific

The Asia-Pacific region is witnessing a 25% rise in pessary adoption, primarily due to increasing healthcare awareness, growing elderly population, and rising disposable incomes. Countries like China, Japan, and India are showing rapid growth, with hospital and retail pharmacy sales rising by 30%. China accounts for 35% of the regional market, as over 60% of elderly women suffer from pelvic organ prolapse but lack access to surgical treatments. India has seen a 20% increase in pessary-related medical consultations, particularly in urban healthcare facilities.

Middle East & Africa

The Middle East & Africa region remains an emerging market, holding approximately 10% of the global share. South Africa and the UAE lead in terms of healthcare accessibility, with a 15% rise in gynecological consultations for pelvic organ prolapse and urinary incontinence. Awareness programs in countries like Saudi Arabia have led to a 25% increase in pessary use. However, lack of trained healthcare professionals and limited product availability remain major challenges, particularly in rural and low-income areas.

List of Key Vaginal Pessary Market Companies Profiled

• Personal Medical Corp
• Smiths Medical
• CooperSurgical
• Dr. Arabin
• Thomas Medical
• Panpac Medical
• Medesign
• Integra LifeSciences
• MedGyn
• Kangge Medical

Top 2 Companies with the Highest Market Share:

1. CooperSurgical – 20% market share
2. Smiths Medical – 15% market share

Investment Analysis and Opportunities

Investments in the vaginal pessary market are on the rise, particularly in R&D for biocompatible materials, product customization, and digital healthcare integration. Medical device companies have increased funding by 35% towards advanced pessary designs, ensuring improved patient comfort and longevity. Additionally, e-commerce investments have grown by 40%, with key players focusing on direct-to-consumer distribution models.

The telemedicine industry has seen a 50% increase in gynecological consultations, creating a major opportunity for pessary manufacturers to expand digital sales. Furthermore, government initiatives in women’s health, particularly in Europe and North America, have led to a 25% increase in product adoption. The growing focus on custom-fitted pessaries, along with 3D printing technology, is expected to reshape the market dynamics over the next few years.

New Product Development

Manufacturers are introducing next-generation pessaries with improved flexibility, biocompatibility, and self-cleaning features. Personal Medical Corp recently launched a new line of customizable silicone pessaries, reducing discomfort by 30% compared to traditional models. Similarly, Smiths Medical introduced a pessary with built-in antimicrobial protection, lowering infection risks by 40%.

Smart pessaries equipped with sensors for tracking pelvic floor pressure and vaginal pH levels are also being explored, with R&D investments increasing by 45%. Moreover, 3D-printed pessaries, which offer better fit and long-term usability, have seen a 25% rise in demand among women with complex pelvic conditions.

Recent Developments by Manufacturers

• CooperSurgical launched a self-adaptive silicone pessary, reducing pressure-related discomfort by 30%.
• Smiths Medical expanded its pessary product line to include antimicrobial-coated models, lowering infection risks by 40%.
• Dr. Arabin introduced a telehealth-compatible pessary fitting system, improving remote patient accessibility by 35%.
• MedGyn increased global pessary distribution, with a 20% rise in product availability in emerging markets.
• Panpac Medical developed a self-cleaning pessary prototype, expected to reduce maintenance efforts by 50%.

Report Coverage

The vaginal pessary market report covers detailed segmentation, regional insights, and competitive landscape analysis, focusing on key factors such as:

• Market trends and future projections, with data on product adoption rates and technological advancements.
• Regional insights, analyzing North America, Europe, Asia-Pacific, and the Middle East & Africa, highlighting growth factors and challenges.
• Competitive landscape, profiling major players like CooperSurgical, Smiths Medical, MedGyn, and Personal Medical Corp.
• Investment analysis, including funding trends, telemedicine impact, and e-commerce growth.
• Product innovations, focusing on self-cleaning pessaries, antimicrobial coatings, and 3D-printed solutions.

With increasing adoption rates, advancements in biocompatible materials, and rising telehealth influence, the vaginal pessary market is set for significant growth in the coming years.